Cited by 42BRCA gene mutations in cancerGenetic factors in colorectal cancerDNA Repair Mechanisms

Identification of a common polymorphism in the TopBP1 gene associated with hereditary susceptibility to breast and ovarian cancer

Karppinen, Sanna-Maria, Erkko, Hannele, Reini, Kaarina, Pospiech, Helmut, Heikkinen, Katri, Rapakko, Katrin, Syväoja, Juhani E., Winqvist, Robert·2006·European Journal of Cancer

Abstract

Besides BRCA1 and BRCA2 other genes are also likely to be involved in hereditary predisposition to breast and/or ovarian cancer. TopBP1 (topoisomerase IIbeta binding protein 1) displays sequence homology as well as functional similarities with BRCA1, and the two proteins have been suggested to function partly in the same cellular processes. TopBP1 is crucial for DNA damage and replication checkpoint controls. Based on its biological significance, we reasoned that TopBP1 is a plausible susceptibility gene for hereditary breast and/or ovarian cancer and therefore screened affected index cases from 125 Finnish cancer families for germline changes by conformation sensitive gel electrophoresis (CSGE). Altogether 19 different sequence alterations were detected. A novel heterozygous Arg309Cys variant was observed at elevated frequency in the familial cancer cases compared to healthy controls (15.2% versus 7.0%; P=0.002). Current results suggest that Arg309Cys is a commonly occurring germline alteration possibly associated with a slightly increased breast and/or ovarian cancer risk. This is the first study reporting mutation screening of the TopBP1 gene in a familial cancer material.

Integrity signals

Registry

Crossref · 10.1016/j.ejca.2006.05.030

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • CHEK2, ATM, NBS1, RAD50, TOPBP1, and RAD51C are mutated in breast cancer patients.

    “Correspondingly, these and other genes functioning in the DNA damage response, such as CHEK2, ATM, NBS1, RAD50, TOPBP1 and RAD51C, are mutated in breast cancer patients [12–21].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Karppinen, S.-M., Erkko, H., Reini, K., Pospiech, H., Heikkinen, K., Rapakko, K., Syväoja, J. E., & Winqvist, R.
Affiliations
  • Oulu University Hospital (FI)
  • University of Oulu (FI)
  • University of Eastern Finland (FI)
Corresponding author
Winqvist, Robert
Venue
European Journal of Cancer
Publisher
Elsevier BV
Published
2006-10
Volume
42
Issue
15
Pages
2647-2652
ISSN
0959-8049 (ISSN-L)
OpenAlex
W1979087808
Cited by
42
References
32
Citations by year
2025: 1 · 2024: 1 · 2022: 2 · 2021: 2 · 2019: 1 · 2018: 1 · 2015: 2 · 2014: 5 · 2013: 4 · 2012: 3
FWCI
2.65
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Cancer (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Academy of Finland
  • Oulun Yliopisto
  • U.S. Bureau of Land Management
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Keywords
TopBP1, hereditary breast cancer, hereditary ovarian cancer, cancer susceptibility genes, germline mutations, DNA damage checkpoint, S-phase checkpoint, mutation detection
MeSH terms
Adult, Breast Neoplasms, Carrier Proteins, DNA-Binding Proteins, Female, Humans, Mutation, Neoplasm Proteins, Nuclear Proteins, Ovarian Neoplasms, Pedigree, Polymorphism, Genetic, Risk Factors, Tumor Cells, Cultured, Blotting, Western, Sequence Analysis, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review